@article{1f435bdaf8d947fe92342c943fdaeadd,
title = "Optimal Exercise Programs for Patients with Peripheral Artery Disease: A Scientific Statement from the American Heart Association",
keywords = "AHA Scientific Statements, exercise, exercise therapy, intermittent claudication, peripheral artery disease",
author = "Diane Treat-Jacobson and McDermott, {Mary M.} and Bronas, {Ulf G.} and Umberto Campia and Collins, {Tracie C.} and Criqui, {Michael H.} and Gardner, {Andrew W.} and Hiatt, {William R.} and Regensteiner, {Judith G.} and Kathleen Rich",
note = "Funding Information: AstraZeneca (clinical trial research grant to study ticagrelor in PAD)*; Bayer (clinical trial research grant to study rivaroxaban in PAD)†; Pluristem (clinical research grant of a stem cell product in PAD)*; NIH (multicenter clinical trial in venous thrombosis)† Funding Information: ACI Medical (supplied pneumatic compression devices for a pilot study)*; Chromadex (supplied drug for study)†; Hershey{\textquoteright}s Company (supplied drug for study)†; NHLBI (funding from 4 ongoing research grants)†; NIA†; PCORI†; Regeneron†; Reserveage (supplied drug for study on resveratrol)*; Viromed (supplied drug for study)†",
year = "2019",
month = jan,
day = "22",
doi = "10.1161/CIR.0000000000000623",
language = "English (US)",
volume = "139",
pages = "E10--E33",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "4",
}